The US government is warning against poop transplantation after a person died of E. coli after the procedure,



[ad_1]

source
Reuters
  • The FDA is warning against possible complications of fecal transplants after one person died and another became ill.
  • Treatments are growing in popularity as an alternative to antibiotics for the treatment of C. diff, a debilitating intestinal infection.
  • It is the first known death of the procedure, which was first approved by the government in 2013.
  • Visit the Business Insider homepage for more stories.

One person died of an e. coli infection from a poop transplant, and the US government is warning that this may happen again.

The Food and Drug Administration on Thursday issued a warning bulletin against possible complications of fecal microbiota transplantation (FMT), which has been growing in popularity for the treatment of C. diff, a debilitating intestinal infection.

"The agency is now aware of bacterial infections caused by multidrug resistant organisms (MDROs) that have occurred due to the transmission of a MDRO from the use of FMT in research," the FDA said.

"Patients considering FMT to treat C. difficile the infection should talk to your health care provider to understand the potential risks associated with using the product. "

Dr. Sahil Khanna, a Mayo Clinic gastroenterologist who performs fecal transplants, told NBC News that it is likely to be the first death of a transplant procedure.

Still, the procedure may work as well as the traditional antibiotics in the treatment of C. diff, which the Center for Disease Prevention and Control infects 500,000 patients every year, many of which fall soon thereafter. In patients over 65, almost 10% died of the infection.

"Recently, fecal microbiota transplantation has been shown to be effective in the treatment of C. difficile infection, "said a study in the New England Journal of Medicine in 2018. Studies have shown that FMT worked as well as antibiotics for the treatment of C. diff.

"This was a small trial, but the results suggest that fecal microbiota transplantation may be an alternative to antibiotic therapy in C. difficile infection, "the authors wrote.

See More Information: IBiome convinced Silicon Valley that the test poop would be worth $ 600 million. Then the FBI came crashing. Here is the story inside.

But after the recent death and illness of a patient, the FDA is warning more protections and exams from donors are needed to prevent others from getting MDRO infections.

"Patients considering FMT to treat C. difficile the infection should talk to your doctor to understand the potential risks associated with using the product, "said the FDA.

[ad_2]

Source link